StockData
AKANNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31

AKANDA CORP.

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Jun 9, 2026
$1.12−0.08 (-6.67%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

About Akanda

Medicinal Chemicals & Botanical Products, SIC 2833

Akanda Corp. is an early-stage company operating primarily through its subsidiary First Towers, alongside a planned cannabis and hemp cultivation business. The company focuses on developing, cultivating, and processing hemp and THC and CBD products, with plans to expand into cannabis oils, extracts, and consumer branded items. Its operations rely on relationships with third-party service providers, suppliers, and distribution partners to reach medical cannabis consumers and broader commercial markets.

The company is incorporated in Canada and maintains its principal executive offices in Toronto, Ontario. Akanda's operational footprint includes a pre-revenue hemp and THC/CBD farming facility in Gabriola Island, British Columbia, as well as business operations in Mexico managed through its First Towers subsidiary. It previously discontinued its historical operational activities across Europe.

Summary of the business section of Akanda's latest annual report, written by StockData.

Company profile

Company

Legal name
AKANDA CORP.
Founded
2021
Headquarters
New Romney, X0
Address
1a, 1b Learoyd Road TN28 8XU
Phone
442034889514
Employees
2, Dec 31, 2024
Industry
Medicinal Chemicals & Botanical Products
Incorporated in
A6
Fiscal year ends
December 31
Auditor
GreenGrowthCPAs, Los Angeles, California

Stock & identifiers

Ticker
AKAN
Exchange
Nasdaq
IPO date
Mar 16, 2022
Shares outstanding
2M, Dec 31, 2025
Filer category
<br>Emerging growth company
Stock splits
1-for-5 reverse, Jan 12, 2026; 1-for-80 reverse, Apr 30, 2025; 1-for-2 reverse, Nov 14, 2024; 1-for-40 reverse, May 23, 2024; 1-for-10 reverse, May 1, 2024; 1-for-10 reverse, Mar 9, 2023
SEC CIK
1888014
CUSIP
00971M700
ISIN
US00971M7002
EIN
00-0000000

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

No recent ownership filings by officers or directors

Akanda's leadership is listed in its proxy statement (Form DEF 14A).

Employees

Headcount reported in annual reports

“As of April 30, 2025, we had no full-time employees and a total of 2 part-time employees who are our executive officers.”

Corporate history

Events identified from SEC filings